Diseases & Disorders
(G12)
990 on File
ADVANCING CANCER TREATMENT
Financial strength (30%)
56/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$43K
Total Revenue
$824K
Total Expenses
$679K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
95.3%
Fundraising Efficiency
N/A
Operating Reserve
9.89x
Liability-to-Asset
4.9%
Revenue Diversification
100.0%
Compared with Peers
FY 2024
Compared with 1,541 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
95.3% | 83.1% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.5% | 10.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.2% | 0.3% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.9 mo | 12.0 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
4.9% | 0.7% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 93.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-97.9% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-34.6% | 9.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-1796.1% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $43K | $824K | $679K | 95.3% | 0 |
| 2023 | $2.1M | $1.3M | $1.5M | 95.8% | 0 |
| 2022 | $3.0M | $3.1M | $647K | 97.7% | 0 |
| 2021 | $3.0M | $820K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.